Literature DB >> 10867312

Processing of context information in schizophrenia: relation to clinical symptoms and WCST performance.

P Stratta1, E Daneluzzo, M Bustini, P Prosperini, A Rossi.   

Abstract

Failure in contextual information processing has been hypothesized as being the single function responsible for several impairments in cognitive tasks and symptoms, through an involvement of the prefrontal cortex, in patients with schizophrenia. A variant of the Continuous Performance Test (CPT) designed specifically to elicit deficits in the processing of contextual information has been administered to 20 schizophrenic patients and 20 healthy controls. The relation to Wisconsin Card Sorting Test (WCST), relatively specific to prefrontal damage and executive dysfunctioning, and clinical status by using scales for the assessment of positive, negative symptoms and outcome has been investigated. The data show that multi-episode schizophrenic patients manifest inability to use contextual information to inhibit habitual response to an ambiguous stimulus and to maintain information across delay, without a general attention deficit. We also found a relationship between contextual reasoning and WCST unique errors, hallucinations, formal thought disorders, and outcome evaluation. Our results further support the hypothesis that the deficit of contextual reasoning could account for cognitive impairments and symptoms of patients with schizophrenia.

Entities:  

Mesh:

Year:  2000        PMID: 10867312     DOI: 10.1016/s0920-9964(99)00142-5

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  19 in total

1.  Changing plans: neural correlates of executive control in monkey and human frontal cortex.

Authors:  Elisa C Dias; Tammy McGinnis; John F Smiley; John J Foxe; Charles E Schroeder; Daniel C Javitt
Journal:  Exp Brain Res       Date:  2006-04-25       Impact factor: 1.972

2.  Disorganization and reality distortion in schizophrenia: a meta-analysis of the relationship between positive symptoms and neurocognitive deficits.

Authors:  Joseph Ventura; April D Thames; Rachel C Wood; Lisa H Guzik; Gerhard S Hellemann
Journal:  Schizophr Res       Date:  2010-06-25       Impact factor: 4.939

3.  OPCML gene as a schizophrenia susceptibility locus in Thai population.

Authors:  Benjaporn Panichareon; Kazuhiro Nakayama; Wanpen Thurakitwannakarn; Sadahiko Iwamoto; Wasana Sukhumsirichart
Journal:  J Mol Neurosci       Date:  2011-07-21       Impact factor: 3.444

4.  DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia.

Authors:  Giuseppe Blasi; Francesco Napolitano; Gianluca Ursini; Paolo Taurisano; Raffaella Romano; Grazia Caforio; Leonardo Fazio; Barbara Gelao; Annabella Di Giorgio; Luisa Iacovelli; Lorenzo Sinibaldi; Teresa Popolizio; Alessandro Usiello; Alessandro Bertolino
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

5.  Differential attenuation of d-amphetamine-induced disruption of conditional discrimination performance by dopamine and serotonin antagonists.

Authors:  Michael J Dunn; Simon Killcross
Journal:  Psychopharmacology (Berl)       Date:  2006-08-30       Impact factor: 4.530

6.  Cognitive predictors of skill acquisition on social problem solving in patients with schizophrenia.

Authors:  Alp Uçok; Sibel Cakir; Zekiye Cetinkaya Duman; Aysun Dişcigil; Pinar Kandemir; Hatice Atli
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06-16       Impact factor: 5.270

7.  Exposure to kynurenic acid during adolescence produces memory deficits in adulthood.

Authors:  Cynthia O Akagbosu; Gretchen C Evans; Danielle Gulick; Raymond F Suckow; David J Bucci
Journal:  Schizophr Bull       Date:  2010-12-20       Impact factor: 9.306

8.  Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis.

Authors:  Joseph Ventura; Gerhard S Hellemann; April D Thames; Vanessa Koellner; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2009-07-22       Impact factor: 4.939

9.  Characterization of non-nitrocatechol pan and isoform specific catechol-O-methyltransferase inhibitors and substrates.

Authors:  Ronald G Robinson; Sean M Smith; Scott E Wolkenberg; Monika Kandebo; Lihang Yao; Christopher R Gibson; Scott T Harrison; Stacey Polsky-Fisher; James C Barrow; Peter J Manley; James J Mulhearn; Kausik K Nanda; Jeffrey W Schubert; B Wesley Trotter; Zhijian Zhao; John M Sanders; Robert F Smith; Debra McLoughlin; Sujata Sharma; Dawn L Hall; Tiffany L Walker; Jennifer L Kershner; Neetesh Bhandari; Pete H Hutson; Nancy A Sachs
Journal:  ACS Chem Neurosci       Date:  2011-11-14       Impact factor: 4.418

10.  Decision-making impairments in the context of intact reward sensitivity in schizophrenia.

Authors:  Erin A Heerey; Kimberly R Bell-Warren; James M Gold
Journal:  Biol Psychiatry       Date:  2008-04-02       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.